Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First in China! Neurophth announced the first patient has been dosed in G.O.L.D. clinical trial for the gene therapy treatment of LHON 2021-06-28 21:33
International experts join Microba Life Sciences inaugural IBD Advisory Panel 2021-06-28 21:00
ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury 2021-06-28 20:00
InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib by US FDA for Treatment of R/R MCL 2021-06-28 16:02
B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology 2021-06-28 15:00
Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery 2021-06-26 23:00
World-first predictive test for Diabetic Kidney Disease could save $384 billion over 10 years 2021-06-25 23:30
I-Mab Announces China NMPA Approval for Phase 1b Trial of Felzartamab in Systemic Lupus Erythematosus 2021-06-25 20:00
InnoCare Announces Approval of Initiation of Phase 1 Clinical Trial of RTK Inhibitor ICP-033 in China 2021-06-25 19:04
Research showed that InxMed FAK Inhibitor (IN10018) Overcomes Drug Resistance of KRAS G12C inhibitors and Synergizes with KRAS G12C inhibitors in Treating Cancer 2021-06-25 15:06
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture 2021-06-25 12:57
Samsung Biologics Issues Its First Annual Sustainability Report 2021-06-25 09:01
Peijia Medical's Jasper® SS Detachable Coil Receives NMPA Approval for Commercialization 2021-06-25 00:27
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE 2021-06-24 20:43
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial 2021-06-23 21:21
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections 2021-06-23 19:28
Senhwa Announces IND Submission to India's CDSCO of a Phase II Clinical Study for Silmitasertib as a Potential COVID-19 Treatment 2021-06-23 19:00
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars 2021-06-23 04:16
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia 2021-06-22 22:32
Asieris Announces First Patient Treated in Europe in APRICITY, the Multinational Phase III Clinical Trial of APL-1702, Cevira® 2021-06-22 13:15
1 141 142 143 144 145 404